Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 65Neoplasms 56Prostatic Neoplasms 44Lung Neoplasms 35Colorectal Neoplasms 35Carcinoma, Non-Small-Cell Lung 24Pancreatic Neoplasms 21Hematologic Neoplasms 19Head and Neck Neoplasms 16Neoplasm Metastasis 15Urinary Bladder Neoplasms 12Ovarian Neoplasms 11Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Motor Activity 10Triple Negative Breast Neoplasms 9Multiple Myeloma 9Colonic Neoplasms 9Melanoma 8Glioma 8Anxiety Disorders 8Uterine Cervical Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 7Glioblastoma 7Gastrointestinal Neoplasms 7Esophageal Neoplasms 7Anatomic Stage I Breast Cancer AJCC v8 7Smoking Cessation 6Sarcoma 6Rectal Neoplasms 6

Interventions

sotrovimab 1ciclesonide 1Standard of Care 1Procalcitonin 1Practice Guidelines as Topic 1Nivolumab 1Niclosamide 1Methods 1Interviews as Topic 1Immune Checkpoint Inhibitors 1High-Intensity Interval Training 1Exercise 1Educational Status 1Early Intervention, Educational 1Cholecalciferol 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lupus Erythematosus, Systemic × Standard of Care × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡